Etuptamig is a chimeric monoclonal antibody of immunoglobulin lambda-chain-gamma1, lambda-chain-gamma3 targeting human natural killer cell cytotoxicity receptor 1 (NCR1). Etuptamig is promising for research of various cancers[1].
Purity:
99
CAS Number:
[3009874-10-3]
Target:
Others
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted